Nancy A. Dreyer

A Practical Guide to Implementing Real‐World Evidence as Primary Basis for Approval and Label Expansion

In June 2026, the FDA issued a revised draft guidance describing the circumstances in which one adequate and well‐controlled clinical investigation plus confirmatory evidence may satisfy the statutory substantial evidence standard for establishing efficacy and safety. Confirmatory evidence includes real‐world evidence...